(Bloomberg) -- A fresh look at how a handful of patients are faring on Pfizer Inc.’s gene therapy for Duchenne muscular dystrophy will be key for investors in competitor Sarepta Therapeutics Inc.Underwhelming effectiveness or new safety issues in this week’s data could remove an overhang for Sarepta shares, which are on their longest winning streak since November. The update will be important in evaluating the competitive landscape before either company starts pivotal trials, wrote RBC Capital Markets analyst Brian Abrahams.RBC expects Pfizer’s presentation at the virtual meeting of the American Society of Gene & Cell Therapy on Friday could trigger a 5% to 10% move in Sarepta shares. Duchenne muscular dystrophy is the core of the company’s pipeline. The two companies are roughly neck-and-neck in drug development for a one-shot therapy to treat patients with the condition, which is marked by progressive muscle weakness and an early death.“We expect Pfizer’s presentation...
Ryanair plans to move back towards an all-Boeing fleet by cancelling leases for Airbus A320s for its Lauda subsidiary and likely replacing 30 Airbus jets at the Austrian airline with Boeing 737s, Chief Executive Michael O'Leary told Reuters. Ryanair's purchase in 2018 of Airbus operator Lauda was pitched as a way to diversify the fleet of the budget airline group, which had until then exclusively flown Boeing jets and currently has over 450 737s. O'Leary, whose expansion plans have been curtailed by the grounding of Boeing's 737 MAX, said in March last year he was in early talks with Airbus about an order for 100 A321s and that Ryanair wanted to have a dual Boeing-Airbus fleet....
(Bloomberg) -- U.S. equity futures edged higher, European stocks gained and Asian shares fell on Tuesday as investors took in stride an up-tick in coronavirus infections in several nations and signs of fresh trade tension. Oil advanced.Contracts on the S&P 500 had fallen after the Trump administration moved on Monday night to block investments in Chinese equities by a government retirement fund, but they recovered through the European morning. The Stoxx 600 Index rose as gains for communications and healthcare shares offset declines for the real estate and energy sectors. Stocks in Hong Kong and India led a broad retreat across Asia. Treasuries fluctuated and the dollar gave up a gain.Global equities have recouped about half of their plunge after hitting a March low, but the sustainability of the rally remains in question amid poor economic data and company earnings and as countries begin to unwind lockdowns that froze economic activity....
